| Symbol: |
RUNDC3B
|
| Description: |
RUN domain containing 3B [Source:HGNC Symbol;Acc:30286]
|
| Location: |
Chr7:87256864-87461611[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:193
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| RUNDC3B |
NSC 116702 |
0.042 |
Down |
| RUNDC3B |
NSC 11865 |
0.006 |
Down |
| RUNDC3B |
NSC 119911 |
0.002 |
Down |
| RUNDC3B |
VERNOLIDE |
0.003 |
Down |
| RUNDC3B |
Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) |
0.032 |
Down |
| RUNDC3B |
as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- |
0.021 |
Down |
| RUNDC3B |
NSC 148201 |
0.001 |
Down |
| RUNDC3B |
NSC 166382 |
0.007 |
Down |
| RUNDC3B |
Bromocriptine methanesulfonate |
0.019 |
Down |
| RUNDC3B |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.019 |
Down |
| RUNDC3B |
NSC 175296 |
0.041 |
Down |
| RUNDC3B |
NSC 18320 |
0.03 |
Down |
| RUNDC3B |
5-CHLORO-6-[[(3,4-DICHLOROPHENYL)AMINO]METHYL]-2,4-QUINOZOLINEDIAMINE |
0.023 |
Down |
| RUNDC3B |
NSC 26112 |
0.024 |
Down |
| RUNDC3B |
1,7-Heptanediamine, N,N'-bis(2-methyl-7-nitro-4-quinolinyl)-, dihydrochloride |
0.048 |
Down |
Expression pattern: Sensitivity / Resistance
Total:13 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:32
Total:3 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|